US CRO Kendle has opened a new services centre in India, attracted by the country’s thriving contract research sector and favourable climate for clinical trials.
The DCGI has banned import of raw materials from 10 Chinese companies which lacked mandatory manufacturing standards, according to The Economic Times of India.
There are signs that 2010 will be a better year for the fine and custom chemistry industry but companies at Informex remained cautious and are planning accordingly.
Millipore has acquired the remaining 60 per cent of its Indian joint venture (JV) to drive growth in the country which it views, along with the other BRICS nations, as a critical part of its strategy.
Reaxa will set up an Indian subsidiary to manage supply chain, commercial scale production and application development for its growing number of customers in the country.
India’s outsourcing sector is growing at 43 per cent, according to a new report that predicts the country will take a bigger share of the global market as concerns about operating there diminish.
Nigeria is collaborating with Interpol and setting up offices in India to curb the flow of counterfeits, in particular allegedly China produced fakes labelled “Made in India”, according to media reports.
India and China share many similarities as outsourcing locations but there are also significant differences that are important to understand before making a commitment, according to a report.
From June onwards drug firms and CROs conducting trials in India are required to record full details of the research, including the funding source, on the ICMR’s Clinical Trials Registry India website.
Researchers believe they have found “more promising” sources of shikimic acid, a precursor in the production of Tamiflu, shortages of which have previously caused bottlenecks in producing the bird flu vaccine.
An Indian doctor has slammed the nation’s clinical trials, claiming they use the vulnerable, the system is corrupt and that the country lacks high quality scientists.
The proportion of global clinical trials conducted In India is expected to more than double between 2007 and 2012, according to market research firm RNCOS.
Postponement of this year’s CPhI and P-MEC India events for “security reasons” may be only the first impact of last week’s Mumbai terror attacks on the country’s outsourcing industry, according to PwC’s life sciences head Sujay Shetty.
The Indian government is planning on establishing pharmaceutical zones at major international airports to facilitate exports, according to local media reports.
The outsourcing of Phase I trials to India may be allowed by 2009-10 after the Central Drugs Standard Control Organisation (CDSCO) said it is considering changing its stance.
Pharmaceutical companies in the developed world have already
shifted substantial manufacturing and clinical trial work to
emerging economies such as China and India, but a new study suggest
they are increasingly counting on these...
Despite the challenges that emerging market present, such as
intellectual property (IP) exposure and drug pricing controls, the
pharma industry is not being deterred.
Novo Nordisk and Merck & Co have both indicated they have their
eye on expanding their drug discovery and manufacturing presence in
India and forging new research partnerships among companies in the
country.
Four of India's biggest vaccine manufacturers have had their
licenses suspended by the Indian government after failing to meet
good manufacturing practise (GMP) requirements, according to local
media reports.
Although India 'has carved out a significant portion of the world
pharma pie', an enormous change in mindset is needed if the country
is to become a global pharmaceutical hub, according to a new report
from KPMG.
India's drug manufacturing industry is tipped to grow 10 per cent
over the next three years as more pharma firms shift operations
there to cut costs, says a research report.
India is the first choice for foreign companies looking to offshore
their knowledge process outsourcing (KPO) activities and future
growth will be fuelled by the pharma market, according to a new
report.
Deprived people are dying because pharmaceutical companies and
worldwide governments of rich countries are obstructing the
developing world from obtaining affordable medicines, according to
a new report.
As it steps up its presence in the major clinical trials
recruitment hubs in Asia, Quintiles has announced its intention to
open a central lab in India to help feed its expanding network of
clinical trial operations in the country.
Indian biopharmaceutical company Wockhardt has signed a deal with
Maharashtra Industrial Development Corporation (MIDC) to establish
a special economic zone (SEZ) in Aurangabad, India, in order to
expand its manufacturing capabilities.
The Japanese pharmaceutical industry is eyeing India as a new hub
to conduct its contract manufacturing and clinical trials - India
is thirsty for new Japanese investment.
New guidelines for the import and manufacture of medical devices in
India have now come into effect, aimed at increasing world
confidence in medical devices made in the region.
Pliva's venture into the Indian subcontinent received a boost as it
was revealed the Governor of Goa would inaugurate the newly built
research and development facility of Pliva Research, India.
Outsourcing-Pharma.com focus on: cutting the cost of clinical trials
Outsourcing-Pharma.com sheds some light on how pharma companies can
make sure they are choosing a contract research organisations (CRO)
that will stick to the rules of ethics when running clinical trials
in poorly-regulated countries...
Outsourcing-Pharma.com focus on: cutting the cost of clinical trials
Outsourcing-Pharma takes a look at how clinical research
organisations (CROs) operating in India can do their best to ensure
that clinical trials in the region are carried out ethically.
Outsourcing-Pharma focus: cutting the cost of clinical trials
After recent allegations in the media that poor and illiterate
patients in India are being used, often unknowingly, as human
guinea pigs to test new drugs for the pharma giants of the West,
Outsourcing-Pharma takes a look at how cutting...
PRA International has bought its first company in India - contract
research organisation (CRO) Sterling Synergy Systems - joining the
growing list of top CROs who have set up operations in this fertile
market.
India is suddenly a safer place to research and manufacture
pharmaceuticals, thanks to legal reform, raised manufacturing
standards and reduced bureaucracy. But risk still lurks in the
loopholes and protectionism.
India is emerging as a powerhouse of pharmaceutical R&D. Backed
by a scientist president and with an army of talented scientists,
the country now has R&D capacity second only to the US, at
one-fifth of the cost.
Chiltern is expanding its clinical trial services business in
India, and in doing so will be the first company to provide
specialised staff recruitment services for the Indian clinical
research industry.
Asia and India are continuing to attract a wave of foreign
outsourcing contracts in the pharma industry, as companies are
lured by productivity-and cost savings. However, these countries
are not yet reaching their potential, as fears...